THUNDER BAY, Ontario (PRWEB)
June 16, 2020

While many businesses are reopening, the threat of COVID-19 is still preventing large gatherings from returning. Sani Pass, a mobile disinfection channel that can be setup at any event, building, or large gathering, can help expedite the opening of these businesses. Using a touch-free disinfection and temperature screening process, Sani Pass gives attendees and organizers added protection against infection.

Mark Zurevinski, CEO of Sani Pass, saw his entire business disappear with the emergence of COVID-19:

“Having been in the entertainment business for decades, we went from 100 to 0% overnight. We explored solutions to help us reopen our business, however there simply wasn’t any— so we built one: Sani Pass. The machine initially detects and verifies that you are wearing a face mask and that your body temperature is within acceptable limits. Hand sanitizer is then dispensed touch-free. Upon stepping into the unit, a natural, non-toxic disinfectant is emitted as a dry fog, leaving absolutely no residue. It’s truly an all-in-one solution for businesses looking to protect their staff and customers from cross-contamination.”

We strongly believe that the use of a Sani Pass disinfection channel, in combination with a proper face mask, helps in the prevention of contracting COVID-19 through cross-contamination when entering a populated space. The mobile disinfection channel is equipped with a proprietary system that disperses a very fine, dry fog of organic, non-toxic, non-irritant disinfection solution. This process assists in protecting individuals when entering a confined area by eliminating 99.9% of germs and viruses that may be present on their skin, clothes and handheld belongings. Sani Pass has also been designed to be handicap accessible.

The solution used within the Sani Pass unit is one of nature’s oldest disinfectants: HOCI. As Heidi Wilcox, Wilcox EVS microbiologist and infection control specialist, explains:

“Infection mitigation systems like Sani Pass that use HOCl are the holy grail of sanitizing and disinfecting. HOCl is, by far, the least toxic disinfectant for humans and the environment. Using HOCl, Sani Pass also cuts down on solid waste, like plastics or cardboard present in other cleaning operations. There are also no synthetic fragrances and dyes in the solution to avoid causing or exacerbating asthma or reducing indoor air quality.”

Sani Pass is touch-free, and the entire process is completed in approximately 8-10 seconds per person, depending on face mask detection, or if other advanced features are enabled.

While we can never expect to return to a world without COVID-19, we must do everything possible to protect people while still allowing them to live and enjoy their lives. Sani Pass is an all-in-one, mobile solution that comes in multiple models to fit a wide range of needs. More info on the different models available can be found on the Sani Pass website.

To learn more about Sani Pass, or to schedule an interview with Sani Pass CEO Mark Zurevinski, please call +1-603-306-3645 or e-mail brian@contentfac.com. You can also check out the Sani Pass website at http://sanipass.net.

Share article on social media or email:

“The prestigious rankings of Orthopedics and Cardiology and Heart Surgery, reflect the expertise and commitment of our entire care team who diligently deliver the region’s highest quality and most innovative pediatric healthcare,” said Caitlin Stella, MPH, CEO, Joe DiMaggio Children’s Hospital.

HOLLYWOOD, Fla. (PRWEB)
June 16, 2020

Joe DiMaggio Children’s Hospital has ranked among the top 50 children’s hospitals in the nation for Orthopedics and Cardiology and Heart Surgery, in the new 2020-21 Best Children’s Hospitals ranking by U.S. News & World Report, the global authority in hospital rankings and consumer advice. The hospital is once again the highest ranked children’s hospital for Pediatric Orthopedics in Florida, and among the 25 best in the U.S., and ranked among the top 50 in the nation for its Cardiology and Heart Surgery program, based on patient outcomes, clinical resources and utilization of best practices.

“It is an honor for Joe DiMaggio Children’s Hospital to be recognized among the top nationally-rated children’s hospitals once again,” said Caitlin Stella, MPH, Chief Executive Officer, Joe DiMaggio Children’s Hospital, Memorial Healthcare System. “The prestigious rankings of Orthopedics and Cardiology and Heart Surgery, reflect the expertise and commitment of our entire care team who works diligently to deliver the region’s highest quality and most innovative pediatric healthcare. It is with great love and compassion for the community we serve that we accept this recognition. We will continue to advocate for children’s health and provide the highest quality care for children right here close to home.”

This recognition reflects the innovative and multidisciplinary medical expertise available at Joe DiMaggio Children’s Hospital. The Department of Orthopedic Surgery is the largest group of fellowship trained pediatric orthopedic surgeons in South Florida, and one of the busiest in the country, providing world class care for a variety of musculoskeletal conditions and sports-related injures affecting children, adolescents and young adults. The Pediatric Heart Institute at Joe DiMaggio Children’s Hospital is one of only three programs in the state offering comprehensive heart care, including congenital heart disease and heart transplantation, and most recently spearheaded a multi-disciplinary team to treat children experiencing MIS-C, an inflammatory illness associated with COVID-19.

“Even in the midst of a pandemic, children have healthcare needs ranging from routine vaccinations to life-saving surgery and chemotherapy,” said Ben Harder, Managing Editor and Chief of Health Analysis at U.S. News. “The Best Children’s Hospitals rankings are designed to help parents find quality medical care for a sick child and inform families’ conversations with pediatricians.”

U.S. News introduced the ‘Best Children’s Hospitals’ rankings in 2007 to help families of children with rare or life-threatening illnesses find the best medical care available. The ratings, according to the publication, are a comprehensive source of quality-related information on U.S. pediatric hospitals and rely on clinical data and on an annual survey of pediatric specialists. The 2019-20 rankings started with 4,653 hospitals, which represent virtually all U.S. community inpatient facilities. The rankings methodology considers clinical outcomes, such as mortality and infection rates, efficiency and coordination of care delivery and compliance with best practices.

About Joe DiMaggio Children’s Hospital

Joe DiMaggio Children’s Hospital is one of South Florida’s leading pediatric hospitals, offering a comprehensive scope of healthcare services and programs in a caring, compassionate setting designed specifically for children. Part of the Memorial Healthcare System, the level one pediatric trauma center combines advanced technology, the expertise of some of the region’s most diverse, board-certified specialists, and a patient and family-centered focus to heal the body, mind, and spirit of those it touches. To learn more, visit jdch.com and connect with @jdchospital on Facebook, Twitter, YouTube and Instagram.

About U.S. News & World Report

U.S. News & World Report is a digital news and information company that empowers people to make better, more informed decisions about important issues affecting their lives. Focusing on Education, Health, Money, Travel, Cars and News, USNews.com provides consumer advice, rankings and analysis to serve people making complex decisions throughout all stages of life. More than 40 million people visit USNews.com each month for research and guidance. Founded in 1933, U.S. News is headquartered in Washington, D.C.

Share article on social media or email:

Breast Cancer Pathology Slide Used to Train a Neural Network

“We quickly identified multiple innovations within the technology and to date, NLP Logix has three issued patents, and more are expected in the future.” – Camille Wilson, a patent attorney at Wilson Dutra.

JACKSONVILLE, Fla. (PRWEB)
June 16, 2020

In late 2015, NLP Logix Lead Data Scientist, Matt Berseth, entered the company into the Camelyon16 Grand Challenge. The Camelyon16 was a challenge for the medical and computer science communities to come together to train a computer to identify breast cancer tumors, at a level at or above the highest trained pathologists in the world. In April 2016, the top five winners were announced, with the combination team of Harvard Medical School and MIT taking first place, and NLP Logix placing fifth, but as the number one commercial entrant. Little did NLP Logix know that their top performing algorithm to identify breast cancer tumors would ultimately be used for another purpose.

The challenge was featured in President Obama’s report on artificial intelligence in healthcare and the results have since been published in numerous healthcare and data science publications. That is the good news. The bad news is that the technology has had limited commercial success. This is unfortunate, since the results of the contest in 2016 declared that the computers had higher detection rates than the humans for the first time, making this a great advancement in medical diagnostics.

Fast forward to 2017 when a large business process outsource company learned about the contest results and asked NLP Logix if the core algorithm could be trained to identify objects in a document image, as well as classify the type of document. The answer was a resounding yes! Today, the core algorithm that was trained to identify breast cancer tumors at a level above a trained pathologist, is now identifying, extracting and classifying millions of document images.

“We worked hard to create the environment, team and technology to deliver world-class machine learning solutions, as proven by how well we did in the Camelyon16,” said Berseth. “We just never would have thought that this same core technology would be re-purposed to process document images.”

The company also felt that their approach and techniques to applying artificial intelligence to image processing was so unique that it would explore pursuing patent protection. NLP Logix contacted Wilson Dutra, a local intellectual property law firm, who conducted an extensive prior art search and confirmed that NLP Logix had really developed a novel approach.

“We were amazed how NLP Logix tackled a decades-long problem with a new and ground-breaking approach to document and image processing,” said Camille Wilson, a patent attorney at Wilson Dutra. “We quickly identified multiple innovations within the technology, and to date, NLP Logix has three issued patents, and more are expected in the future.”

NLP Logix has been marketing the solution under the name ScribeFusion and has achieved data capture rates over 40% higher than traditional optical character recognition (OCR), and accuracy rates above 95% when classifying a document type. The company has also developed a technique to identify sensitive information, like credit card numbers, social security numbers, names, etc., and blur them from the document images to support regulatory compliance.

Share article on social media or email:

We are excited to partner with Pivot Point Consulting to accelerate getting these data-driven insights into healthcare organizations so that they can get employees back to work, patients back in for routine care and return to revenue faster.

NASHVILLE, Tenn. (PRWEB)
June 16, 2020

Pivot Point Consulting, a national healthcare IT consulting leader and the 2020 Best in KLAS Overall IT Services Firm, announces it will bolster its back to work services by creating an ecosystem that combines the power of its core solutions with a strategic partnership with Jvion, industry leader for clinical-AI prescriptive analytics.

Jvion helps healthcare organizations prevent avoidable patient harm and lower costs through the use of prescriptive analytics that identify patients on a health-risk trajectory, determines if that trajectory can be changed, and if so, recommends patient-specific interventions. Applied to the pandemic, Jvion’s clinical-AI CORE™ identifies vulnerable patients with the greatest risk of morbidity and mortality if infected with COVID-19. Healthcare organizations utilize this information to deploy interventions and prioritize patients for hospitalization and prevent avoidable hospital utilization for other conditions. Additionally, organizations are leveraging Jvion’s CORE to identify vulnerability across their workforce to prevent exposure and risk and inform back-to-work health and wellness strategies.

“We’re doubling down on back to work solutions to keep pace with and anticipate the needs of today’s rapidly changing market,” says Rachel Marano, Co-Founder and Managing Partner. “We’re thrilled to be working with Jvion to bring game-changing, cost-effective solutions to our clients. Jvion is doing amazing, innovative work so they’re a natural complement to our KLAS-ranked healthcare IT services.”

Jvion’s AI-powered assessments drive workforce wellness, organizational value, as well as member, patient and employee safety. The outcomes-supported tool is additive to existing reactive screening measures (thermal scanning, contact tracing), but provides a far more prescriptive approach.

Jay Deedy, Jvion CEO, says “Identifying employee risk is only one piece of the puzzle. Understanding and monitoring vulnerability on an ongoing basis is what really helps maintain workforce health and wellness and protect the greater community. We are excited to partner with Pivot Point Consulting to accelerate getting these data-driven insights into healthcare organizations so that they can get employees back to work, patients back in for routine care and return to revenue faster.”

According to Marano, “Now, more than ever, organizations need to build a trusted, sustainable ecosystem. We’re focused on staying close to the market, understanding the gaps and filling them quickly with services and strategic partnerships to truly provide comprehensive solutions, support and value in this new environment where innovative, rapid responses have never been more important.”

About Pivot Point Consulting

Pivot Point Consulting, 2020 Best in KLAS: Overall IT Services Firm, enables healthcare organizations to realize the most value from their technology and data through our Advisory, Implementation, Optimization, Managed Services and Talent Solutions. We work with provider and payer organizations and have 450+ employees serving over 100 clients across the U.S. Pivot Point Consulting has earned many industry and workplace quality awards including: Best in KLAS: Overall IT Services Firm (2020) , Top Three Best in KLAS for HIT Implementation and Support (2015, 2016, 2017, 2018, 2019) , Highest Rated Vendor in KLAS Implementation Services in the Select Category (2017) , #1 in KLAS for Epic Consulting in the Select Category (2016) , #9 in Modern Healthcare’s Best Places to Work (2016)

Practices: Epic®, Community Connect®, Cerner®, Siemens®, Allscripts®, MEDITECH®, McKesson®, Centricity®, eClinicalWorks®, NextGen® CPSI®, MEDHOST®, athenahealth®, Greenway®, Workday®, Lawson/Infor®, Peoplesoft®, SAP®, Kronos® and Facets®.

For more information, visit us at pivotpointconsulting.com. Follow us on LinkedIn.

About Jvion

Jvion enables healthcare organizations to prevent avoidable patient harm and lower costs through its clinical AI solution. An industry first, the Jvion CORE goes beyond simple predictive analytics and machine learning to identify patients on a trajectory to becoming high risk and for whom intervention will likely be successful. Jvion determines the interventions that will more effectively reduce risk and enable clinical action. And it accelerates time to value by leveraging established patient-level intelligence to drive engagement across hospitals, populations, and patients. To date, the Jvion CORE has been deployed across about 50 hospital systems and 300 hospitals, who report average reductions of 30% for preventable harm incidents and annual cost savings of $6.3 million. For more information, visit http://www.jvion.com.

Share article on social media or email:

Gateway Genomics

Any Lab Test Now puts lab results directly in the control of the customer, which is the same benefit SneakPeek provides to parents everywhere, the ability to learn their baby’s gender in their own control.

LA JOLLA, Calif. (PRWEB)
June 16, 2020

Gateway Genomics, leading developer of direct-to-consumer genetic tests that give families insight into their future children, teams with Any Lab Test Now, a leading provider of convenient and affordable lab testing services, to offer SneakPeek Early Gender DNA tests. This partnership adds a scientifically-validated 99.1% accurate fetal sex test to Any Lab Test Now’s arsenal of DNA-based products, while quickly growing SneakPeek’s already expansive base of clinical locations in the US.

“The SneakPeek Early Gender DNA Test is a great fit in Any Lab Test Now locations,” says Gateway Genomics CEO, Chris Jacob. “Both brands aim to make reliable, accurate DNA information easy and accessible to anyone. Any Lab Test Now allows customers to choose a lab test online and schedule an appointment with any of their locations or even walk in for same day testing. It puts lab results directly in the control of the customer, which is the same benefit SneakPeek provides to parents everywhere, the ability to learn their baby’s gender in their own timeline and control.”

The SneakPeek Early Gender DNA Test was first offered in Any Lab Test Now in 2019, spurred by growing customer requests for a product that determined fetal sex. With the product’s popularity and success, SneakPeek quickly expanded into additional Any Lab Test Now locations and is now currently offered in a third of the franchises. With the new partnership established across the full network, SneakPeek is expected to roll out to all 180+ Any Lab Test Now locations by the end of this year.

“Any Lab Test Now is a great addition to the clinical locations who currently offer SneakPeek,” continues Mr. Jacob. “The labs are essential businesses, which means they are accessible when our other providers may not be. In addition to our SneakPeek Early Gender At-Home product, which can be ordered online and taken by moms at home rather than through a clinical visit, this enables our customers to always have access to their test-taking method of choice.”

In 2019, Gateway Genomics ranked #236 in the 38th annual Inc. 500|5000 list of fastest-growing private companies in the U.S., #23 in the Health sector. In this year’s Inc. 5000 California list, the company was ranked the 17th fastest-growing private company in the state, and #1 in the Health sector. Gateway Genomics’ principal product, SneakPeek, is an easy-to-use DNA test that lets parents know the gender of their babies as early as 8 weeks into pregnancy, with 99.1% accuracy.

About Gateway Genomics

Gateway Genomics is a personal genomics company with the mission to develop leading-edge genetic tests that give families a new level of understanding about their future children. Since inception, more than 200,000 SneakPeek Early Gender DNA tests have been provided to help new parents bond with their babies, make plans, and connect with friends and family around them. Gateway Genomics is located in La Jolla, CA.

Share article on social media or email: